ABL Bio and GSK Partner on Neurodegenerative Disease Therapies with Grabody-B Platform
South Korea-based clinical-stage biotech ABL Bio Inc. (KOSDAQ: 298380) has entered into a licensing agreement...
KOSDAQ: 298380
Biocytogen and ABL Bio Forge Partnership to Advance Bispecific ADC Development
China-based Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (HKG: 2315) has entered into a partnership with South...